Skip to main content

Bruker Corp(BRKR-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Latest News

Biognosys and Alamar Biosciences Forge Strategic Partnership in Proteomics to Advance Biopharma and Precision Medicine Research
GlobeNewswire - Thu Apr 4, 7:11AM CDT
GlobeNewswire
Thu Apr 4, 7:11AM CDT
BRKR
Chart of the Day: Bruker Measures Up
Barchart - Fri Mar 8, 7:00AM CST
Barchart
Fri Mar 8, 7:00AM CST
The Chart of the Day belongs to the medical instruments company Bruker (BRKR) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart...
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
GlobeNewswire - Tue Jan 23, 7:00AM CST
GlobeNewswire
Tue Jan 23, 7:00AM CST
Biognosys Presents Technological Innovations and Scientific Progress to Make the Proteome Actionable for Life Science Research at the HUPO 2023 World Congress
GlobeNewswire - Fri Sep 15, 2023
GlobeNewswire
Fri Sep 15, 2023
PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker
PR Newswire - Tue Sep 5, 2023
PR Newswire
Tue Sep 5, 2023
/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL) today announced that Bruker Corporation (Nasdaq: BRKR) has commenced, through its wholly owned subsidiary, Bird...
Biognosys Unveils Innovative Workflow for Deep and Reproducible Plasma Proteomics, Enabling Breakthroughs in Molecular Diagnostics and Drug Development
GlobeNewswire - Wed Jun 7, 2023
GlobeNewswire
Wed Jun 7, 2023
Bruker Announces Acquisition of ZONTAL to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions
Business Wire - Mon May 8, 2023
Business Wire
Mon May 8, 2023
Bruker Corporation (Nasdaq: BRKR) today announced that is has closed the acquisition of ZONTAL Inc . ( www.zontal.io ), an innovative platform provider for the digital transformation of the analytical laboratory, and for integrated biopharma...
Bruker Reports First Quarter 2023 Financial Results
Business Wire - Thu May 4, 2023
Business Wire
Thu May 4, 2023
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2023.
Bruker Announces Date and Time of First Quarter 2023 Earnings Release and Webcast
Business Wire - Wed Apr 26, 2023
Business Wire
Wed Apr 26, 2023
Bruker Corporation (Nasdaq: BRKR) today announced it will report first quarter 2023 financial results before market opening on Thursday, May 4, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the...
Bruker Advances NMR Magnet Portfolio, Innovates in Industrial Solutions
Business Wire - Mon Apr 17, 2023
Business Wire
Mon Apr 17, 2023
At the Experimental Nuclear Magnetic Resonance Conference (ENC 2023), Bruker announces innovations for NMR spectroscopy in life science, pharma, and cleantech research to enable discoveries in functional structural biology, drug discovery, and...
PreOmics Introduces a Novel BeatBox™ FFPE Workflow for Accelerated, In-depth Tissue Proteomics
Business Wire - Fri Apr 14, 2023
Business Wire
Fri Apr 14, 2023
At the AACR Annual Meeting 2023, PreOmics GmbH announced the launch of a BeatBox-based FFPE workflow, which simplifies, speeds up and standardizes FFPE sample preparation for deep, unbiased tissue proteomics by subsequent protein digestion and...
Bruker Introduces New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper®, and a Novel LiquidArray® Gastrointestinal Syndromic Panel
Business Wire - Fri Apr 14, 2023
Business Wire
Fri Apr 14, 2023
At the 33rd European Congress of Clinical Microbiology & Infectious Diseases ( www.eccmid.org ), Bruker Corporation (Nasdaq: BRKR) announced its latest innovations for user-friendly, best-in-class diagnostic solutions for routine clinical...
Canopy Biosciences and Enable Medicine Announce Partnership to Bring Advanced Spatial Analysis Pipelines to the ChipCytometry Platform
Business Wire - Wed Apr 12, 2023
Business Wire
Wed Apr 12, 2023
Canopy Biosciences, a Bruker Company, and Enable Medicine, today announced a partnership to provide Enable Medicine’s advanced analysis pipelines for spatial omics data with the Canopy CellScape ™ system for quantitative high-plex spatial...
For Number Cruncher column in Globe Investor/ROB only.
13 U.S. health care stocks starting to shine again
The Globe and Mail - Thu Apr 6, 2023
The Globe and Mail
Thu Apr 6, 2023
We are looking for U.S. health care stocks benefiting as the sector is making gains
Bruker Announces Two 1.2 GHz NMR Systems Orders from the UK
Business Wire - Fri Mar 17, 2023
Business Wire
Fri Mar 17, 2023
Bruker announces that the United Kingdom is expanding its fundamental research infrastructure with recent orders for two 1.2 GHz Avance ™ nuclear magnetic resonance (NMR) spectrometers for the University of Warwick and the University of...
Bruker Launches de novo Sequencing for Immunopeptidomics, Library-Free dia-PASEF, Mass Dynamics Knowledge Visualization
Business Wire - Mon Mar 6, 2023
Business Wire
Mon Mar 6, 2023
At the 19th US HUPO, Bruker Corporation (Nasdaq: BRKR) announced important bioinformatics launches for 4D-Proteomics on the timsTOF platform: A novel de novo sequencing algorithm was developed in collaboration with Rapid Novor Inc., using over...
The European Gauss Fusion Initiative Seeks to Use Magnetic Fusion to Ensure a Clean and Safe Energy Supply
Business Wire - Tue Feb 28, 2023
Business Wire
Tue Feb 28, 2023
Gauss Fusion GmbH is a greentech venture founded in 2022 by various European companies from Germany, France, Italy and Spain with extensive experience in fusion technology. In February 2023, Gauss Fusion completed a founders’ pre-seed financing...
Bruker Corporation to Present at Investor Conferences
Business Wire - Wed Feb 22, 2023
Business Wire
Wed Feb 22, 2023
Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the following investor conferences:
Bruker Announces Quarterly Dividend
Business Wire - Fri Feb 17, 2023
Business Wire
Fri Feb 17, 2023
Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on March 17, 2023 to...
3 Mid-Cap Earnings Plays to Watch This Week
MarketBeat - Tue Feb 14, 2023
MarketBeat
Tue Feb 14, 2023
Mid-caps could continue to be the hot hand for traders and investors alike. Keep an eye on these three upcoming earnings reports.
Bruker Reports Fourth Quarter and Fiscal Year 2022 Financial Results
Business Wire - Thu Feb 9, 2023
Business Wire
Thu Feb 9, 2023
Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the fiscal year ended December 31, 2022.
Bruker Announces Successful Customer Installations of First Two Compact 1.0 GHz NMR Systems to Advance Structural Biology
Business Wire - Fri Feb 3, 2023
Business Wire
Fri Feb 3, 2023
Bruker today announced successful customer installations of two novel, compact 1.0 GHz NMR spectrometers for advanced structural and molecular biology applications well ahead of original schedules in late 2022. Both new Ascend Evo 1.0 GHz ...
Bruker Announces Date and Time of Fourth Quarter 2022 Earnings Release and Webcast
Business Wire - Tue Jan 31, 2023
Business Wire
Tue Jan 31, 2023
Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2022 financial results before market opening on Thursday, February 9, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern...
Bruker Announces Acquisition of ACQUIFER Imaging GmbH
Business Wire - Thu Jan 5, 2023
Business Wire
Thu Jan 5, 2023
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of ACQUIFER Imaging GmbH , a pioneer in big-data management solutions for bioimaging and high-content microscopy. This acquisition adds high-performance on-premise processing,...
Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers
Business Wire - Wed Jan 4, 2023
Business Wire
Wed Jan 4, 2023
Bruker Corporation (Nasdaq: BRKR) and Switzerland-based Biognosys AG today announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys. Financial details were not disclosed. J.P.Morgan acted as...